Teletherapy and radiopharmaceutical therapy of painful bone metastases

Seminars in Nuclear Medicine

Volumn 35, Issue 2, 2005, Pages 152-158

  Silberstein, Edward B ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Society of Nuclear Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID RE 186; LEXIDRONAM SAMARIUM SM 153; PENTETIC ACID; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; RHENIUM 186; RHENIUM 188; SAMARIUM 153; STRONTIUM 89; TIN;

ALGORITHM; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE EXACERBATION; HUMAN; LEUKOCYTE; LUNG CANCER; PANCYTOPENIA; PATIENT SATISFACTION; PROSTATE CANCER; THROMBOCYTE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 17644380961     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2004.11.006     Document Type: Article

References (47)

1. K.M. Foley The treatment of cancer pain N Engl J Med 313 1985 84 95
2. A.H. Reddi, D. Roodman, C. Freeman Mechanisms of tumor metastasis to bone Challenges and opportunities J Bone Miner Res 18 2003 190 194
3. H.L. Abrams, R. Spiro, N. Goldstein Metastases in carcinoma. Analysis of 1000 autopsied cases Cancer 23 1950 74 85
4. World Health Organization Cancer pain relief and palliative care. Report of a WHO expert committee World Health Organ Tech Rep Ser, 804 1990 World Health Organization Geneva, Switzerland 1 75
5. O.S. Nielsen, A.J. Munro, I.F. Tannock Bone metastases Pathophysiology and management policy J Clin Oncol 9 1991 509 524
6. A.T. Porter, A.J.B. McEwan, J.E. Powe Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int J Rad Oncol Biol Phys 25 1993 805 813
7. S.M. Tu, R.E. Millikan, B. Megistu Bone-targeted therapy for androgen-independent carcinoma of the prostate A randomized Phase II trial Lancet 357 2001 336 341
8. 89Sr therapy for painful bone metastases from prostate cancer A randomized clinical trial J Nucl Med 43 2002 79 86
9. H.P. Greenwald, J.J. Bonica, M. Bergner The prevalence of pain in four cancers Cancer 60 1987 2563 2569
10. H.S. Poulson, O.S. Neilsen, M. Klee Palliative irradiation of bone metastases Cancer Treat Rev 16 1989 41 48
11. P.J. Hoskin Palliation of bone metastases Eur J Cancer 27 1991 950 951
12. D. Tong, L. Gillick, F.R. Hendrickson The palliation of symptomatic osseous metastases. Final results of the study by the Radiation Therapy Oncology Group Cancer 50 1982 893 899
13. P. Price, P.J. Hoskin, D. Easton Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases Radiother Oncol 6 1986 247 255
14. C.M. Rose, A.R. Kagen The final report of the expert panel for the radiation oncology bone metastases working group of the ACR Int J Radiat Oncol Biol Phys 40 1998 117 120
15. O.M. Salazar, P. Rubin, F.R. Hendrickson Single dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group Report Cancer 58 1986 29 36
16. G.M. Blake, M.A. Zivanovic, A.J.B. McEwan Sr-89 therapy Strontium kinetics in disseminated carcinoma of the prostate Eur J Nuc Med 12 1986 447 454
17. W.A. Volkert, E.A. Keutsch Bone-seeking radiopharmaceuticals in cancer therapy Advances Metals Med 1 1991 115 153
18. R.C. Samaratunga, S.R. Thomas, J.D. Hinnefeld A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186 (Sn)-HEDP J Nucl Med 36 1995 336 350
19. C. Urch The pathophysiology of cancer-induced bone pain current understanding Palliat Med 18 2004 267 274
20. N. Pandit-Taskar, M. Batraki, C.R. Divgi Radiopharmaceutical therapy for palliation of bone pain from osseous metastases J Nucl Med 45 2004 1358 1365
21. P. Honore, S.D. Rogers, M.J. Schwei Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons Neuroscience 98 2000 585 598
22. P.W. Mantyh, D.R. Clohisy, M. Koltzenburg Molecular mechanisms of cancer pain Nat Rev Cancer 2 2002 201 209
23. E.B. Silberstein The treatment of painful osseous metastases with phosphorus-32-labeled phosphates Semin Oncol 20 suppl 2 1993 10 21
24. 89Sr in palliation in skeletal metastases J Nucl Med 40 1999 256 261
25. J. Fettich, A. Padhy, N. Nair Comparative clinical efficacy and safety of phosphorus-32 and strontium-89 in the palliative treatment of metastatic bone pain Results of an IAEA coordinated research project World J Nucl Med 2 2003 226 231
26. C. Pecher Biological investigations with radioactive calcium and strontium Preliminary report on the use of radioactive strontium in treatment of metastatic bone cancer U Cal Public Pharmacol 11 1942 117 149
27. E.B. Silberstein, C. Williams Strontium-89 therapy for the pain of osseous metastases J Nucl Med 26 1985 345 348
28. R.G. Robinson, D.F. Preston, J.A. Spicer Radionuclide therapy of intractable bone pain Emphasis on strontium-89 Semin Nucl Med 22 1992 28 32
29. A.J.B. McEwan, A.T. Porter, D.M. Vennes An evaluation of the safety and efficacy of treatment with strontium-89 in patients who have previously received wide field radiotherapy Antibody Immunoconjugates Radiopharm 3 1990 91 98
30. P.M. Quilty, D. Kirk, J.J. Bolger A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer Radiother Oncol 31 1994 33 40
31. A. Zyskowski, D. Lamb, P. Morum Strontium-89 treatment for prostate cancer bone metastases Does a prostate-specific antigen response predict for improved survival? Australas Radiol 45 2001 39 42
32. S.L. Turner, S. Gruenewald, N. Spry Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer Br J Cancer 84 2001 297 302
33. R. Sciuto, C.L. Maini, A. Tofani Radiosensitization with low-dose cisplatin enhances pain palliation in radioisotope therapy with strontium-89 Nucl Med Commun 17 1996 799 804
34. H.R. Maxon, S.R. Thomas, V.S. Hertzberg Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases Semin Nucl Med 22 1992 33 40
35. N. Quirijnen, S.H. Han, B.A. Zonnenberg Efficacy of rhenium-186 etidronate in prostate cancer patients with metastatic bone pain JMSP J Nucl Med 37 1996 1511 1515
36. K. Liepe, W.G. Franke, J. Kropp Comparison of rhenium-188, rhenium-186-HEDP, and strontium-89 in palliation of painful bone metastases Nuklearmedizin 39 2000 146 151
37. 188Re hydroxyethylidenediphosphonate J Clin Oncol 21 2003 2869 2875
38. R.A. Holmes [153Sm] EDTMP A potential therapy for bone cancer pain Semin Nucl Med 22 1992 41 45
39. G.J. Dickie, D. Macfarlane Strontium and samarium therapy for bone metastases from prostate carcinoma Australas Radiol 43 1999 476 479
40. S.C. Srivastava, H.L. Atkins, G.T. Krishnamurthy Treatment of metastatic bone pain with tin-117m stannic diethyltriaminepentaacetic acid A phase I/II clinical study Clin Cancer Res 4 1998 61 68
41. A. Dafermon, P. Colamussi, M. Giganti A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer Eur J Nucl Med 28 2001 788 798
42. A.J.B. McEwan, G.A. Amyotte, D.G. McGowan A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone Eur Urol 26 suppl 1994 26 31
43. I. Malmberg, U. Persson, A. Ask Painful bone metastases in hormone-refractory prostate cancer economic costs of strontium-89 and/or external radiotherapy Urol 50 1997 747 753
44. R.P. Viney, D. Hayne, M. Ayra Pharmacological management of metastatic boney pain Expert Opin Pharmacother 5 2004 1555 1563
45. J.E. Browne, H. Neville-Webbe, R.E. Coleman The role of bisphosphonates in breast and prostate cancers Endocr Relat Cancer 11 2004 207 224
46. T.S. Powles, S. Paterson, J.A. Kanis Randomized placebo-controlled trial of clodronate in patients with primary operable breast cancer J Clin Oncol 20 2002 3219 3224
47. C. Roemer-Becuwe, I. Krakowski, T. Conroy Bisphosphonates, pain and quality of life in metastatic breast cancer patients A literature review Bull Cancer 90 2003 1097 1105